• Contact
• About APA
• Site Map

• Psychiatric Practice
  • Addiction Psychiatry
  • Ethics
  • Managing Your Practice
  • Medicare Medicaid
  • Practice Guidelines
  • Quality Improvement
• Education & Career Development
  • Educational Initiatives
  • Lifelong Learning & CME
  • Medical Students
  • Meetings
  • Melvin Sabshin Library & Archives
  • Residents
• Research
  • DSM
  • International Programs
  • Psychiatric Research Report
  • Health Policy Analysis
  • APIRE
  • Practice Research Network and Health Services Research
  • Research Training and Funding
  • Education Fellowships and Training
  • Research Colloquium for Junior Investigators
  • Endowment Campaign
• Advocacy
  • Communications & Public Affairs
  • Financing Health Care
  • Government Relations
  • Multimedia
  • Political Action Committee
• Newsroom
  • Annual Reports
  • APA Member & DB-SA Resources
  • News Releases
• Members Corner

• Home
• Research
• DSM
• DSM-V
• Meet the Task Force
• Compton

Wilson M. Compton, M.D., M.P.E.

Name, Degree: Wilson M. Compton, M.D.
Role(s) in Task Force: Task Force Member
Institutional Affiliation(s): National Institute on Drug Abuse, National Institutes of Health
City, State: Bethesda, MD

Biographical Sketch: 

Member, DSM-V Task Force
Director, Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Bethesda, MD

Wilson M. Compton, M.D., M.P.E. is Director of the Division of Epidemiology, Services and Prevention Research at the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. Prior to joining NIDA, Dr. Compton was Associate Professor of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at the Washington University in Saint Louis as well as Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis. Dr. Compton received his undergraduate education from Amherst College. He attended medical school and completed his residency training in psychiatry at Washington University. He is a member of the Alpha Omega Alpha honor society as well as number professional organizations. He has been the principal or co-principal investigator of multiple federally funded grants focusing on the epidemiology of drug abuse, HIV prevention and co-occurring mental and drug use disorders. In these areas of research, Dr. Compton has authored over 100 articles and chapters, and several diagnostic interviews. 

Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V :   Three calendar years before  nomination and Each year thereafter through the present calendar year.  (For 2008, activities to date and commitments for remainder of year.)

The two tables below represent Dr. Compton's disclosure of significant interests and affiliations for:  (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.

Dr. Compton has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.

Disclosure of significant interests including:  The time period January 1, 2005 to the present.